Skip to main content
OpenTrials
Completed

NCT Number: NCT01992302

Risk Factors for Development of Rapid Cycling in Bipolar Disorder Patients

In this study we tried to elucidate the factors associated with the development of a rapid cycling course in bipolar disorder patients, in a prospective and longitudinal design, and the role of antidepressants. The identification of risk factors is extremely relevant from the clinical point of view. We hypothesized that rapid cycling bipolar disorder is associated with more chronicity, poor outcome, and more antidepressant prescription.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Barcelona Bipolar Disorders Program, Hospital Clinic Barcelona

Barcelona, Catalonia, 08037, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Bipolar I and II disorder patients according to DSM-IV criteria

Exclusion criteria

  • Major medical comorbidities, voluntary drop-out from study

Treatment and study plan

Primary outcomes

  1. Number of patients who develop rapid cycling

    Time frame: 8 years

Secondary outcomes

  1. Factors associated with the development of a rapid cycling course in bipolar disorder patients

    Time frame: 8 years

Sponsors and collaborators

Lead sponsor

Hospital Clinic of Barcelona

Other

Registry information

Important dates

Study start
2004
Primary completion
2013
Study completion
2013
First posted
Nov 25, 2013
Registry last updated
Nov 25, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.